Pancreatic cancer: Advances and challenges

Christopher J Halbrook1, Costas A Lyssiotis2, Marina Pasca di Magliano3

  • 1Department of Molecular Biology and Biochemistry, University of California, Irvine, Irvine, CA 92697, USA; Institute for Immunology, University of California, Irvine, Irvine, CA 92697, USA; Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA 92868, USA.

Cell
|April 14, 2023
PubMed
Summary

Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer. Understanding its complex tumor microenvironment and metabolic alterations is key to improving patient survival rates.